Mode
Text Size
Log in / Sign up
Phase 2 Completed N=17 Treatment

BLI4700-202: A Pilot Evaluation of BLI4700 Bowel Preparation in Adult Subjects

Colonoscopy
Source: ClinicalTrials.gov NCT03103581 ↗
Enrolled (actual)
17
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcomePrimary: Proportion of Subjects With Successful Bowel Preparation — 15 Participants

Summary

The objective of this study is to evaluate the safety and efficacy of BLI4700 as a bowel preparation prior to colonoscopy in adult patients.

Outcome Measures

OutcomeResultp-value
PRIMARY
Proportion of Subjects With Successful Bowel Preparation
15

Eligibility Criteria

Primary Inclusion Criteria:

  • Male or female outpatients who are undergoing colonoscopy for a routinely accepted indication.
  • At least 18 years of age
  • If female, and of child-bearing potential, is using an acceptable form of birth control.
  • Negative urine pregnancy test at screening, if applicable
  • In the Investigator's judgment, subject is mentally competent to provide informed consent to participate in the study

Primary Exclusion Criteria:

  • Subjects with known or suspected ileus, severe ulcerative colitis, gastrointestinal obstruction, gastric retention, bowel perforation, toxic colitis or megacolon.
  • Subjects who had previous significant gastrointestinal surgeries.
  • Subjects with uncontrolled pre-existing electrolyte abnormalities, or those with clinically significant electrolyte abnormalities based on Visit 1 laboratory results.
  • Subjects with a prior history of renal, liver or cardiac insufficiency
  • Subjects with impaired consciousness that predisposes them to pulmonary aspiration.
  • Subjects undergoing colonoscopy for foreign body removal and/or decompression.
  • Subjects who are pregnant or lactating, or intending to become pregnant during the study.
  • Subjects of childbearing potential who refuse a pregnancy test.
  • Subjects allergic to any preparation components.
  • Subjects who, in the opinion of the Investigator, should not be included in the study for any reason, including inability to follow study procedures.
  • Subjects who have participated in an investigational surgical, drug, or device study within the past 30 days.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03103581). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search